Physician Assistant in Fort Stewart, GA Accepting Medicare

108 Physician Assistant nurses found. Showing 101 - 108

Ms. Andrea Mcknight Mcelveen, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-435-6965

Ms. Daiana Lynn Frym, PA Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave Ste 1d03, Fort Stewart, GA 31314 Phone: 912-435-5595

Bryan Anderson, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-315-8354

John Edward Balser, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-435-6633

Israel Zachary Hagains, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-435-6965

Ms. Nykeba S Braddy, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1061 Harmon Ave Ste 1d03, Fort Stewart, GA 31314 Phone: 912-435-6633    Fax: 912-435-6633

Karen Long, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-435-6965

Charles Brad Delong, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 352-428-6785

News Archive

Parental supervision at ages 11-14 lowers risk for problem gambling by age 22

Keeping an eye on your child can lower their odds for gambling by young adulthood, according to research conducted at Columbia University's Mailman School of Public Health. Adolescents who had poor parental supervision at age 11, and which continued to decline through age 14, were significantly more likely than their peers to be problem gamblers between ages 16-22.

Hydroxychloroquine shows no antiviral effect on SARS-Cov-2 in non-human primate models

A study on the effects of hydroxychloroquinei n macaques infected with the SARS-CoV-2 virus, , used alone or in combination with azithromycin, have been pre-published on Research Square, after their submission to Nature.

Incyte announces positive results from ongoing Phase I/II clinical trial for INCB7839

Incyte Corporation announced today positive results from an ongoing Phase I/II clinical trial for its selective oral sheddase inhibitor, INCB7839, involving 46 patients with HER2 positive metastatic breast cancer.

Altair Therapeutics initiates its IL-4 receptor alpha inhibitor bronchoprovocation phase 2 trial

Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.

Merck announces results from ISENTRESS Phase III combination study on HIV-1

Merck, known as MSD outside the United States and Canada, today announced results of new exploratory pre-specified analyses from the ongoing STARTMRK Phase III study of its integrase inhibitor ISENTRESS (raltegravir) Tablets in combination therapy compared to efavirenz in combination therapy in previously untreated adult HIV-1-infected patients.

Read more Medical News

› Verified 9 days ago

• 1
• 2
• 3
• 4
• 5
• 6(current)